Display options
Cite
Chan G, White CC, Winn PA, et al. Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci. Neurol Genet. 2016;2(4):e90doi: 10.1212/NXG.0000000000000090.
Chan, G., White, C. C., Winn, P. A., Cimpean, M., Replogle, J. M., Glick, L. R., Cuerdon, N. E., Ryan, K. J., Johnson, K. A., Schneider, J. A., Bennett, D. A., Chibnik, L. B., Sperling, R. A., De Jager, P. L., & Bradshaw, E. M. (2016). Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci. Neurology. Genetics, 2(4), e90. https://doi.org/10.1212/NXG.0000000000000090
Chan, Gail, et al. "Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci." Neurology. Genetics vol. 2,4 (2016): e90. doi: https://doi.org/10.1212/NXG.0000000000000090
Chan G, White CC, Winn PA, Cimpean M, Replogle JM, Glick LR, Cuerdon NE, Ryan KJ, Johnson KA, Schneider JA, Bennett DA, Chibnik LB, Sperling RA, De Jager PL, Bradshaw EM. Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci. Neurol Genet. 2016 Jul 26;2(4):e90. doi: 10.1212/NXG.0000000000000090. eCollection 2016 Aug. PMID: 27504496; PMCID: PMC4962525.
Copy Download .nbib Format: NLM
Share it on

Neurol Genet. 2016 Jul 26;2(4):e90. doi: 10.1212/NXG.0000000000000090. eCollection 2016 Aug.

Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci.

Neurology. Genetics

Gail Chan, Charles C White, Phoebe A Winn, Maria Cimpean, Joseph M Replogle, Laura R Glick, Nicole E Cuerdon, Katie J Ryan, Keith A Johnson, Julie A Schneider, David A Bennett, Lori B Chibnik, Reisa A Sperling, Philip L De Jager, Elizabeth M Bradshaw

Affiliations

  1. Ann Romney Center for Neurologic Diseases (G.C., C.C.W., P.A.W., M.C., J.M.R., L.R.G., N.E.C., K.J.R., L.B.C., P.L.D.J., E.M.B.), Program in Translational NeuroPsychiatric Genomics (G.C., C.C.W., P.A.W., M.C., J.M.R., L.R.G., N.E.C., K.J.R., L.B.C., P.L.D.J., E.M.B.), Institute for the Neurosciences, Departments of Neurology and Psychiatry, Center for Alzheimer's Research and Treatment (K.A.J., R.A.S.), Department of Neurology, Brigham and Women's Hospital, Boston, MA; Program in Medical and Population Genetics (G.C., C.C.W., P.A.W., M.C., J.M.R., L.R.G., N.E.C., K.J.R., L.B.C., P.L.D.J., E.M.B.), Broad Institute, Cambridge, MA; Harvard Medical School (G.C., J.M.R., K.J.R., K.A.J., L.B.C., R.A.S., P.L.D.J., E.M.B.), Boston, MA; Department of Neurology (K.A.J., R.A.S.), Massachusetts General Hospital, Boston; and Rush Alzheimer's Disease Center (J.A.S., D.A.B.), Rush University Medical Center, Chicago, IL.

PMID: 27504496 PMCID: PMC4962525 DOI: 10.1212/NXG.0000000000000090

Abstract

OBJECTIVE: Given evidence from genetic studies, we hypothesized that there may be a shared component to the role of myeloid function in Parkinson and Alzheimer disease (PD and AD) and assessed whether PD susceptibility variants influenced protein expression of well-established AD-associated myeloid genes in human monocytes.

METHODS: We repurposed data in which AD-related myeloid proteins CD33, TREM1, TREM2, TREML2, TYROBP, and PTK2B were measured by flow cytometry in monocytes from 176 participants of the PhenoGenetic Project (PGP) and Harvard Aging Brain Study. Linear regression was used to identify associations between 24 PD risk variants and protein expression. The 2 cohorts were meta-analyzed in a discovery analysis, and the 4 most strongly suggestive results were validated in an independent cohort of 50 PGP participants.

RESULTS: We discovered and validated an association between the PD risk allele rs12456492(G) in the RIT2 locus and increased CD33 expression (p joint = 3.50 × 10(-5)) and found strongly suggestive evidence that rs11060180(A) in the CCDC62/HIP1R locus decreased PTK2B expression (p joint = 1.12 × 10(-4)). Furthermore, in older individuals, increased CD33 expression on peripheral monocytes was associated with a greater burden of parkinsonism (p = 0.047), particularly bradykinesia (p = 6.64 × 10(-3)).

CONCLUSIONS: We find that the rs12456492 PD risk variant affects expression of AD-associated protein CD33 in peripheral monocytes, which suggests that genetic factors for these 2 diseases may converge to influence overlapping innate immune-mediated mechanisms that contribute to neurodegeneration. Furthermore, the effect of the rs12456492(G) PD risk allele on increased CD33 suggests that the inhibition of certain myeloid functions may contribute to PD susceptibility, as is the case for AD.

References

  1. Nat Genet. 2011 May;43(5):436-41 - PubMed
  2. Alzheimers Res Ther. 2015 Apr 15;7(1):41 - PubMed
  3. J Biol Chem. 1998 Apr 17;273(16):9361-4 - PubMed
  4. Cell. 2010 Mar 19;140(6):918-34 - PubMed
  5. J Parkinsons Dis. 2013;3(4):493-514 - PubMed
  6. Nat Rev Neurosci. 2014 May;15(5):300-12 - PubMed
  7. Science. 2015 Feb 6;347(6222):664-7 - PubMed
  8. J Leukoc Biol. 2001 Aug;70(2):322-8 - PubMed
  9. Nat Genet. 2014 Sep;46(9):989-93 - PubMed
  10. Nat Neurosci. 2013 Jul;16(7):848-50 - PubMed
  11. J Immunol. 2000 Feb 15;164(4):2028-36 - PubMed
  12. Mol Neurobiol. 2016 Sep;53(7):4931-8 - PubMed
  13. Hum Mol Genet. 2014 May 15;23(10):2729-36 - PubMed
  14. Ann Neurol. 2012 Feb;71(2):258-66 - PubMed
  15. Hum Mol Genet. 2015 Jun 15;24(12):3557-70 - PubMed
  16. Bioinformatics. 2012 Mar 15;28(6):882-3 - PubMed
  17. Bioinformatics. 2010 Sep 1;26(17):2190-1 - PubMed
  18. Curr Alzheimer Res. 2012 Jul;9(6):646-63 - PubMed
  19. Neuroepidemiology. 2005;25(4):163-75 - PubMed
  20. Nat Genet. 2011 May;43(5):429-35 - PubMed
  21. Mol Neurodegener. 2013 Jun 21;8:19 - PubMed
  22. Int J Geriatr Psychiatry. 2014 Jun;29(6):569-76 - PubMed
  23. J Gerontol A Biol Sci Med Sci. 1999 Apr;54(4):M191-6 - PubMed
  24. Nat Genet. 2013 Dec;45(12):1452-8 - PubMed
  25. Nat Neurosci. 2015 Nov;18(11):1556-8 - PubMed
  26. Eur J Immunol. 2005 Jan;35(1):243-51 - PubMed
  27. Neuron. 2013 May 22;78(4):631-43 - PubMed
  28. Curr Alzheimer Res. 2012 Jul;9(6):628-45 - PubMed
  29. Ann Neurol. 2006 Mar;59(3):449-58 - PubMed
  30. Semin Immunol. 2015 Feb;27(1):51-7 - PubMed
  31. Mol Psychiatry. 2015 Dec;20(12):1588-95 - PubMed
  32. Ann Neurol. 2011 Dec;70(6):897-912 - PubMed
  33. Science. 2014 May 2;344(6183):519-23 - PubMed

Publication Types

Grant support